Literature DB >> 22440640

Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems.

G Scrascia1, C Rotunno, D Nanna, R Rociola, P Guida, G Rubino, L de Luca Tupputi Schinosa, D Paparella.   

Abstract

Cell saving systems are commonly used during cardiac operations to improve hemoglobin levels and to reduce blood product requirements. We analyzed the effects of residual pump blood salvage through a cell saver on coagulation and fibrinolysis activation and on postoperative hemoglobin levels. Thirty-four elective coronary artery bypass graft (CABG) patients were randomized. In 17 patients, residual cardiopulmonary bypass (CPB) circuit blood was transfused after the cell saving procedure (cell salvage group). In the other 17 patients, residual CPB circuit blood was discarded (control group). Activation of the coagulative, fibrinolytic and inflammatory systems was evaluated pre-operatively (Pre), 2 hours after the termination of CPB (T0) and 24 hours postoperatively (T1), measuring prothrombin fragment 1.2 (PF 1.2), plasmin-anti-plasmin (PAP), plasminogen activator inhibitor-1 (PAI-1) and interleukin-6 (IL-6). The cell salvage group of patients had a significant improvement in hemoglobin levels after processed blood infusion (2.7 ± 1.7 g/dL vs 1.2 ± 1.1 g/dL; p=0.003). PF1.2 levels were significantly higher after infusion (T0: 1175 ± 770 pmol/L vs 730 ± 237 pmol/L; p=0.037; T1: 331 ± 235 pmol/L vs 174 ± 134 pmol/L; p=0.026). Also, PAP levels were higher in the cell salvage group, although not significantly (T0: 253 ± 251 ng/mL vs 168 ± 96 ng/mL; p: NS; T1: 95 ± 60 ng/mL vs 53 ± 32 ng/mL; p: NS). No differences were found for PAI-1, IL-6, heparin levels or for red blood cell (RBC) transfusions. The cell salvage group of patients had increased chest tube drainage (749 ± 320 vs 592 ± 264; p: NS) and fresh frozen plasma transfusion rate (5 (29%) pts vs 0 pts; p<0.04). Pump blood salvage with a cell saving system improved postoperative hemoglobin levels, but induced a strong thrombin generation, fibrinolysis activation and lower fibrinolysis inhibition. These conditions could generate a consumption coagulopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440640     DOI: 10.1177/0267659112442236

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  9 in total

Review 1.  Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients.

Authors:  Bo Zhai; Xue-Ying Sun
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

2.  The Influence of Intraoperative Autotransfusion on Postoperative Hematocrit after Cardiac Surgery: A Cross-Sectional Study.

Authors:  Andrew J Stasko; Alfred H Stammers; Linda B Mongero; Eric A Tesdahl; Samuel Weinstein
Journal:  J Extra Corpor Technol       Date:  2017-12

3.  Effects of circuit residual volume salvage reinfusion on the postoperative clinical outcome for pediatric patients undergoing cardiac surgery.

Authors:  Lifen Ye; Ru Lin; Yong Fan; Lijun Yang; Jianling Hu; Qiang Shu
Journal:  Pediatr Cardiol       Date:  2012-12-13       Impact factor: 1.655

4.  Efficacy of intraoperative cell salvage in decreasing perioperative blood transfusion rates in first-time cardiac surgery patients: a retrospective study.

Authors:  Claudia L Côté; Alexandra M Yip; Jeffrey B MacLeod; Bill O'Reilly; Joshua Murray; Maral Ouzounian; Craig D Brown; Rand Forgie; Marc P Pelletier; Ansar Hassan
Journal:  Can J Surg       Date:  2016-09       Impact factor: 2.089

5.  The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.

Authors:  Yihong Xie; Sheliang Shen; Jun Zhang; Wenyuan Wang; Jiayin Zheng
Journal:  Int J Med Sci       Date:  2015-04-01       Impact factor: 3.738

Review 6.  Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA.

Authors:  Patrick Meybohm; Suma Choorapoikayil; Anke Wessels; Eva Herrmann; Kai Zacharowski; Donat R Spahn
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

7.  Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.

Authors:  Sheliang Shen; Jun Zhang; Wenyuan Wang; Jiayin Zheng; Yihong Xie
Journal:  J Transl Med       Date:  2016-07-29       Impact factor: 5.531

8.  The Effect of Cell Salvage on Bleeding and Transfusion Needs in Cardiac Surgery.

Authors:  Frixos Tachias; Evangelia Samara; Anastasios Petrou; Agathi Karakosta; Stavros Siminelakis; Efstratios Apostolakis; Petros Tzimas
Journal:  Anesthesiol Res Pract       Date:  2022-09-01

9.  The effects on coagulation of the reinfusion of unprocessed residual blood from the cardiopulmonary bypass.

Authors:  Yolande-Leigh Iyer; Philip Hayward; Larry McNicol; Laurence Weinberg
Journal:  BMC Res Notes       Date:  2016-02-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.